Cargando…
Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus
The health burden of Parkinson’s disease (PD) and diabetes increases rapidly in China. However, no population-based study of the association between glucose lowering agents and PD incidence has been conducted in mainland Chinese population. Preclinical studies indicate that thiazolidinediones (TZDs)...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587207/ https://www.ncbi.nlm.nih.gov/pubmed/36271052 http://dx.doi.org/10.1038/s41531-022-00406-8 |